Last month, Pfizer announced plans to end its new drug research efforts for Alzheimer's and Parkinson's diseases—a devastating blow for those seeking therapeutic developments for neurodegenerative disease.

November marks Alzheimer’s disease (AD) awareness month. For the last several years, the Milken Institute Center for Strategic Philanthropy (CSP) has been digging deep into the role philanthropic capital can...

Seeking to better understand collaboration in biomedical R&D? FasterCures has added more than 80 consortia profiles to Consortia-pedia, a searchable catalogue of 500+ profiles of research collaborations.

The Milken Institute Center for Strategic Philanthropy has launched an Epilepsy Giving Smarter Program, informing philanthropists on the state of the science for epilepsy and highlighting impactful philanthropic opportunities ripe for investment.

Soaring costs for many prescription medications — including promising new breakthrough drugs — is compelling pharmaceutical companies and insurers to look for new ways to provide the most effective treatments...

Five scientists whose medical innovations literally have the potential to change the future offered insights into their discoveries during the Global Conference session “This Changes Everything: How Technology Is Revolutionizing...